Extramural Funding Opportunities

This is an accordion element with a series of buttons that open and close related content panels.

NIDDK FUNDING ANNOUNCEMENTS

NOSI, K12, F99/K00, P20, and RC2 AWARDS

High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) The purpose of the High Impact, Interdisciplinary Science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK.  The interdisciplinary approach encouraged by this FOA is envisioned to generate a research resource and/or foster discovery-based or hypothesis-generating science that can have a significant impact on the broader scientific community. This FOA seeks novel approaches in areas that address specific knowledge gaps, scientific opportunities, new technologies, data generation, or research methods that will advance the area in significant ways designed to accelerate scientific progress in the understanding, treatment, and prevention of diseases within the mission of the NIDDK. Posted 11/30/2021.  LOI due six weeks prior to application due date. Expires 10/31/24.

The Kidney, Urology or Hematology (KUH) Predoctoral to Postdoctoral Transition Award (F99/K00) The purpose of the Kidney, Urology or Hematology (KUH) Predoctoral to Postdoctoral Transition Award (F99/K00) is to recruit truly exceptional graduate students from diverse research fields, and provide them a stable transition into a postdoctoral research experience focused on K, U, or H research. Strong candidates will bring novel approaches and diverse perspectives from fields including, but not limited to, engineering, statistics, data science, imaging, biochemistry, neuroscience and genetics. Graduate students who are already involved in K, U, or H research are now ELIGIBLE for this F99/K00 award: https://grants.nih.gov/grants/guide/notice-files/NOT-DK-24-012.html. Prospective applicants are strongly encouraged to contact the NIDDK Program Official early in the process to discuss eligibility and program goals. Posted 3/17/2022. Expires 4/2/2025.

Notice of Special Interest (NOSI): Addressing Health Disparities and Advancing Health Equity in NIDDK Diseases This NOSI invites applications for research to understand and mitigate health disparities in the prevention, development, diagnosis, treatment and progression of diseases and conditions of high priority to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It is recognized that health disparities are driven by factors operating at multiple levels (i.e., individual, interpersonal, community, societal) and domains (e.g., biological, behavioral, sociocultural, physical/built environment, etc.) and interacting in complex ways. (Refer to the NIMHD Minority Health and Health Disparities Research Framework.) Research approaches may include observational, interventional, and dissemination and implementation research studies in representative populations. Basic science studies including animal models are responsive if they clearly justify how the proposed research will serve to advance health equity or address a known disparity. Posted 12/20/2023. Expires 1/8/2027.

R21 AWARDS

Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to provide support for new investigators from diverse backgrounds, including from groups nationally underrepresented in biomedical, clinical, behavioral and social sciences research, to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) or the National Human Genome Research Institute (NHGRI). New investigators at the time of award under this FOA will have had less than $125,000 direct costs of combined research funding (excluding NIH training and NIH career awards). This R21 will support small research projects that can be carried out in a short period of time with limited resources and seeks to facilitate transition to research independence. The R21 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. Posted 8/20/2021. Standard due dates. Expires 9/8/2024.

Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) This FOA is intended to support tool or technology development projects that will open new areas of science or translational research. The projects supported by this FOA must involve development activities, which could include prototyping of a new tool or significant improvement, adaptation, or optimization of an existing technology for the unique anatomy or physiology of KUH systems. In addition to development activities, projects may also include proof-of-concept studies and refinement of technical specifications for subsequent deployment of the technology in laboratory or clinical settings. Independent proof-of-concept studies or hypothesis-driven research, without any technological development activities, will not be supported by this FOA. The tools and technologies developed under this FOA should be truly innovative and break new ground or extend previous discoveries toward new directions or applications. Applications to this FOA should include projects distinct from those that can be supported through the traditional R01 grant mechanism. This FOA is not intended to support “mini-R01s” with a traditional hypothesis-driven research plan. Furthermore, long-term projects, or projects designed to increase knowledge in a well-established area, are not appropriate for this FOA. Strong applications will develop new tools or technologies in kidney, urology or hematology with broad utility beyond the applicant’s own laboratory and ideally push the entire field forward. Posted 4/11/2023. Expires 1/8/2025.

RO1 AWARDS

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Funding Opportunity Announcement (FOA) must not include preliminary data. Applications must include a separate attachment describing the change in research direction. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs), including the NIDDK, based on their scientific missions. This Funding Opportunity Announcement does not accept applications proposing clinical trials. Posted 12/20/2023. Expires 12/29/2026.

COOPERATIVE AGREEMENT AWARDS (U series)

NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed) This NOFO invites applications for investigator-initiated, high-risk multi-center observational studies involving more than one clinical center. Proposed studies should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission and are not permitted under this NOFO. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see PAR-24-094). Consultation with NIDDK Scientific/Research Staff strongly encouraged prior to the submission of either a U34 or U01 application. Posted 1/4/2024. Expires 11/6/2026.

NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required) This NOFO invites applications for investigator-initiated, high-risk multi-center clinical trials involving more than one clinical center. Proposed trials should be hypothesis-driven, have the potential to change clinical practice and/or public health, and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission and are not permitted under this NOFO. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see PAR-24-094). Consultation with NIDDK Scientific/Research staff is strongly encouraged prior to the submission of either a U34 or U01 application. Posted 1/4/2024. Expires 11/6/2026.

NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) NIDDK supports investigator-initiated, high-risk multi-center (more than one center) clinical studies through a two-part process that may include an implementation planning cooperative agreement (U34). The U34 is designed to: 1) Permit early peer review of the rationale for the proposed clinical study; 2) Permit assessment of the design and protocol of the proposed study; 3) Provide support for the development of documents needed for the conduct of the study, including a manual of operations; and 4) Support the development of other essential elements required for the conduct of the clinical study. The proposed clinical study should be hypothesis-driven and focus on a disease in the mission of NIDDK. Consultation with NIDDK scientific staff is strongly encouraged prior to the submission of the U34 application. Posted 1/4/2024. Expires 6/11/2027.

OTHER AWARDS

Innovative Science Accelerator Program (ISAC) The ISAC Award provides seed funding for exceptionally innovative, disruptive (high-risk/high-reward) research relevant to Kidney-Urologic-Hematologic communities that has the potential to lead to groundbreaking or paradigm-shifting results that will change the field. ISAC awards are NOT Pilot & Feasibility projects for the generation of more preliminary data for traditional NIH applications (e.g., R01). Three-page applications are accepted on a rolling basis and reviewed three times a year. Investigators may request up to $100,000 (direct + indirect costs) total costs for one year. Standard application due dates: April 15, Aug 15, Dec 15.

HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery The purpose of this Notice of Special Interest (NOSI) is to encourage the development, validation, and replication of animal models that recapitulate the phenotypic and physiologic characteristics of a defined pain type/indication and/or disease-associated pain condition and endpoints or outcome measures that can be used therein. The goal of this NOSI is to improve the translational application of animal models and/or outcome measures for the development of non-addictive analgesics. Ideally, models or measures proposed for this NOSI would have the potential to provide feasible and meaningful assessments of efficacy following therapeutic intervention that would be applicable in both preclinical and clinical settings. This NOSI is not specific for any one or group of pain conditions. Projects focused on acute pain, chronic pain, painful neuropathy, musculoskeletal pain, headache disorders, osteoarthritis, diabetic neuropathy, chemotherapy-induced neuropathy, eye pain, sickle-cell pain, post-surgical pain, cancer pain, visceral pain, obstetric pain, gynecologic pain, post stroke pain, myofascial pain, painful disorders of the orofacial region, pain co-occuring with substance use disorders, and other conditions will be considered. In addition to replication and validation of more commonly used translational animal models of pain, the development of animal models of pain for understudied pain conditions, age groups or less developed models is also encouraged. Posted 7/14/2022. Expires 6/25/2025.

NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed) The NIDDK Central Repository houses valuable biological samples and data from numerous major clinical studies. This initiative allows investigators to apply for access to non-renewable samples from one or more of these studies. Information about the samples available can be found at the Repository’s website. Applicants must include a volume and impact assessment report from the NIDDK Central Repository with the X01 Application to document sample availability. Posted 6/29/2022. Expires 6/27/2025.

Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed) The purpose of this Notice of Funding Opportunity (NOFO) is to support established biomedical data resources, that have demonstrated impact and have potential for continued benefit to the mission of one or more of the NIH Institutes and Centers participating in this announcement. Each resource must: (a) deliver scientific impact to the communities served; (b) employ and promote good data management practices (as outlined by the FAIR Data Principles including adherence to the NIH desirable characteristics of repositories) and efficient operations for quality and services; (c) engage with the user community and continuously address their needs; and (d) support a process for data life-cycle analysis, long-term preservation, and trustworthy governance. Funding FAQ: https://datascience.nih.gov/faq-par-23-236-and-par-23-237. Posted 8/30/2023. Expires 1/26/2026.

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed) The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) whose research is supported by specific types of research grants that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting, mentoring, and supporting high school, undergraduate and graduate/clinical students, postbaccalaureate and post Masters individuals, postdoctoral researchers (including health professionals), and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to support PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. The activities proposed in the supplement application must fall within the scope of the parent grant, and simultaneously advance the objectives of the parent grant and support the research training and professional development of the supplement candidate. Posted 6/29/2023. Expires 5/8/2026.

Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed) The purpose of this funding opportunity is to enhance the sustainability and impact of research software tools by enabling the use of best practices and design principles in software development and by leveraging continuing advances in computing. The Building Sustainable Software Tools for Open Science (R03) funding opportunity is intended to provide a flexible mechanism to support the use of best practices for scientific software development and to promote community engagement for open science. Successful grants will enable and/or enhance biomedical, clinical, behavioral, social, and health-related research endeavors by (1) developing robust, sustainable, scalable, and reproducible research software tools and workflows, (2) extending the impact of research software by broader dissemination to the scientific community, (3) supporting collaborations between scientists and software engineers to leverage modern, best practices in research software development, and (4) enhancing software skills of the research workforce. This initiative is aligned with the NIH Strategic Plan for Data Science, which describes actions aimed at building a better data infrastructure and a modernized data ecosystem. Posted 7/17/2024. Expires 12/5/2026.

OTHER NIH FUNDING ANNOUNCEMENTS

NIH Loan Repayment Plan (LRPs):

The NIH Loan Repayment Programs (LRPs) are a set of programs established by Congress and designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers. The escalating costs of advanced education and training in medicine and clinical specialties are forcing some scientists to abandon their research careers for higher-paying private industry or private practice careers. The LRPs counteract that financial pressure by repaying up to $50,000 annually of a researcher’s qualified educational debt in return for a commitment to engage in NIH mission-relevant research. Since tomorrow’s medical breakthroughs will be made by investigators starting in their research careers today, the LRPs represent an important investment by NIH in the future of health discovery and the wellbeing of the Nation.

From the National Institute on Aging:

Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) This FOA allows for applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Such projects will likely involve an integrated multidisciplinary team of investigators within a single institution or a consortium of institutions. Posted 7/7/2022. Expires 9/26/2025.

From other NIH institutes:

  • Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) National Center for Complementary and Integrative Health. The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate the development of effective precision probiotic interventions using a milestone-driven, biphasic award mechanism. It aims to identify, understand, and develop strategies to address barriers in precision probiotic interventions to account for the heterogenicity in humans that often causes inconsistent probiotic therapeutic responses.
  • Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity MOSAIC Postdoctoral Career Transition Award to Promote Diversity (K99/R00). The purpose of this program is to support a cohort of early career, independent investigators from diverse backgrounds conducting research in NIH mission areas. The long-term goal of this program is to enhance diversity in the biomedical research workforce. The MOSAIC K99/R00 program is designed to facilitate a timely transition of promising postdoctoral researchers from diverse backgrounds (e.g., see Notice of NIH’s Interest in Diversity) from their mentored, postdoctoral research positions to independent, tenure-track or equivalent research-intensive faculty positions. Two awards are available: (1) K99/R00 Independent Clinical Trial Not Allowed; and (2) K99/R00 – Independent Clinical Trial Required. Posted 8/17/2021. Standard due dates. Expires 9/8/2024.
  • Large Research Projects for Prevention of Healthcare-Associated Infections (R01) This Funding Opportunity Announcement (FOA) invites grant applications for funding to conduct Large Research Projects (R01) that propose to advance the base of knowledge for detection, prevention, and reduction of Healthcare-Associated Infections (HAIs). Posted 7/7/2021. Standard due dates. Expires 5/27/2025.
  • Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed) This Notice of Funding Opportunity (NOFO) supports the development of early-stage or new data repositories or knowledgebases that could be valuable for the biomedical research community. The overall goal is to support pilot activities that demonstrate the need and potential impact of the data resource. The NOFO will also support transitioning resources that are currently supported as investigator-initiated research efforts into quality controlled, standards-based resources that address governance, and efficiency of operations. Efforts to consolidate existing data repositories or independent knowledgebases are also in scope for this NOFO. Each resource must: (a) deliver scientific impact to the communities served; (b) employ and promote good data management practices (as outlined by the FAIR Data Principles including adherence to the NIH desirable characteristics of repositories) and efficient operations for quality and services; (c) engage with the user community and continuously address their needs; and (d) support a process for data life-cycle analysis, long-term preservation, and trustworthy governance. Funding FAQ: https://datascience.nih.gov/faq-par-23-236-and-par-23-237. Posted 8/30/2023. Expires 1/26/2026.

INSTITUTION-SPECIFIC CTSA STAKEHOLDER ENGAGEMENT FUNDING

*Follow the links to specific funding opportunities for more detailed information regarding deadlines and requirements. The deadlines for some of the following opportunities may have passed but have been identified as reoccurring opportunities.


Albert Einstein College of Medicine – Institute for Clinical & Translational Research (ICTR) Funding

  • Catalytic Seed Grants
    • We invite applications from faculty members seeking seed funding to provide data for the development of extramural grant applications. Awards of up to $5,000 will be provided to investigators who will acquire new data to generate proposals for additional funding. Funds must be used for projects that will use ICTR Cores and Resources. Applications must be planned in consultation with the director(s) of the core or resource, who will help develop and approve the requested budget. Funds may not be used to purchase equipment or for salary support. Projects supported under this program must be clinical or translational in design or implementation. Priority for funding will be given to the current ICTR focus areas: (1) Pediatric determinants of adult health, (2) Experimental therapeutics, (3) Patient-centered outcomes research utilizing Montefiore Health System data.

Columbia University – Irving Institute for Clinical & Translational Research (IICTR) Funding

  • Collaborative and Multidisciplinary Pilot Research (CaMPR) General and Integrating Special Populations (ISP) Pilot Award
    • The CaMPR and CaMPR-ISP program focuses on the innovative assembly of new teams to gather preliminary data to address unresolved clinical, translational and public health problems with novel approaches informed by interdisciplinary and multidisciplinary collaboration. Projects that use a community-engaged approach to research are encouraged (CECR).
  • Community-Based Participatory Research Scholars and Awards Program
    • The Community Based Participatory Research Scholars and Awards Program is an innovative training and pilot funding opportunity for Columbia University faculty and administrators of not-for-profit organizations serving Upper Manhattan and The Bronx. The CBPR Program is designed to foster community-engaged research by giving participants structured training and practical experience in CBPR methodology. Up to five academic-community dyads are selected for the course. Academic-community co-instructors teach the CBPR course to model the partnership process. Upon completion of the training course, dyads are eligible to apply for a one-year CBPR pilot award of $30,000.

Duke University –Clinical & Translational Science Institute (CTSI) Funding

  • Duke/NCCU Collaborative Translational Research Awards
    • This pilot program is designed to facilitate novel clinical, population, and translational research that applies or accelerates discovery into testing in clinical or population settings. Projects must demonstrate stakeholder engagement and a high translational potential with a clear path for continued development to move into clinical practice, generate new clinical guidelines, or other applications via subsequent grant support, new company formation, licensing, not-for-profit partnering, an evidence base that changes practice or other channels.
  • Duke/NC State Translational Research Agreement
    • This pilot program is designed to facilitate novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings. Projects must demonstrate stakeholder engagement and high translational potential with a clear path for continued development to move into clinical practice, generate new clinical guidelines, or other applications via subsequent grant support, new company formation, licensing, not-for-profit partnering, an evidence base that changes practices, or other channels.
  • Duke CTSI Special Populations Pilot
    • The purpose of the Special Populations Pilot program is to facilitate novel clinical and translational research that promotes health equity for groups who have traditionally been under-represented in health research or excluded altogether. Projects must have strong potential to inform subsequent grant applications for external funding. Pilot awards will be $25,000 (direct costs only); applications that include a strong community stakeholder-academic partnered approach will be eligible for an additional $10,000 for a total of $35,000 in pilot funding for a team that includes a strong community stakeholder-academic partnered approach. (see Community-Engaged Approaches below). Proposals from early stage and new investigators and proposals with collaborations across Duke Departments or Schools are highly encouraged.
  • CTSI Translational Accelerator Research Funding Agreement
    • The Duke CTSI Translational Accelerator Research Funding Agreement provides up to $125,000 (direct costs only) to support novel translational research that applies or accelerates discovery into testing in clinical or population settings. Projects must demonstrate stakeholder engagement and high translational potential for continued development to move into clinical practice, generate new clinical guidelines, or other applications via subsequent grant support, new company formation, licensing, not-for-profit partnering, an evidence base that changes practice, or other channels.
  • CTSI Population Health Improvement Awards Program
    • This Awards program aims to engage community and academic partners in collaborative research that promotes novel ideas to improve community and population health. Duke CTSI, home of the National Institutes of Health’s Clinical and Translational Science Award at Duke, will provide approximately $100,000 annually to support pilot awards that can be used to either a) develop new community-research partnerships or b) foment already existing community and research partnerships that aim to develop and test effective solutions to improve community and population health. These partnerships and innovations can originate from community stakeholders or from Duke research partners but they must involve both community and research collaborators.
  • Duke CTSI Multidisciplinary Vision Program (MVP) Award 
    • The Duke CTSI Multidisciplinary Vision Program (MVP) Award provides funding up to $110,000 per award to support novel clinical translational research focused on improving health and healthy equity. Duke CTSI supports clinical translational research endeavors under the following domains: Methods/Processes, Collaboration/Engagement, Informatics, Integration Across the Lifespan, and Workforce Development. Proposals from teams of investigators from different disciplines are encouraged. Collaborations that bring together ideas, theories, methods and approaches from disparate scientific disciplines are particularly encouraged.

Mayo Clinic – Center for Clinical and Translational Science (CCATS) Funding

Stanford University – Stanford Center for Clinical and Translational Research and Education (Spectrum) Funding

  • Spectrum Community Engagement Pilot Grant 
    • Spectrum offers pilot grants for accelerating clinical and translational research in biomedical and health-related areas. The Spectrum Pilot Program has two major goals: to stimulate innovative clinical and translational research and to encourage collaborative, transdisciplinary work. The primary expectation is that these early-stage translational projects will lead to additional research, external support, information dissemination, and most importantly, will develop into longer-term, comprehensive projects. The projects must have a community engagement component that highlights ways to incorporate community members’ input in the design and implementation of the proposed project.

University of Alabama at Birmingham – Center for Clinical & Translational Science (CCTS) Funding

  • CCTS Interdisciplinary Network Pilot Program
    • Through the CCTS Pilot Program, we seek to (a) ameliorate disparities in diseases that disproportionately affect minority and special populations across the CCTS Partner Network and (b) develop the future translational research workforce by fostering collaboration, team science and innovative discovery. Special consideration will be given to projects that include community-engaged research.
  • Voucher Programs
    • The mission of the Center for Clinical and Translational Science (CCTS) is to address disparities and diseases disproportionately represented within the Deep South as we accelerate discovery to improve human health. Vouchers help overcome barriers to conducting mission-aligned investigation by connecting investigators with clinical, translational or community-based research goals to the facilities, resources and expertise they need. Vouchers are intended for active research efforts that are ready to use these resources immediately.

University of California San Francisco – Clinical & Translational Science Institute (CTSI) Funding

  • Pilot for Research on Racism Impacting Black People
    • The UCSF Office of Research has committed to the goal of anti-racism and racial equity in research. As one action for this initiative, the Office of Research has convened campus partners to create an anti-racism research pilot grant program. Funding for this initiative is provided by the Clinical and Translational Science Institute (CTSI), Academic Senate, School of Medicine’s Research Evaluation and Allocation Committee (REAC), and the Research Development Office. Community-academic partnerships are encouraged and may include local, county, or state governments, police departments, court systems, and/or high-impact nonprofits or community-based organizations.
  • Team Science Grant
    • The goal of this award is to spark innovation by stimulating new collaborations between researchers from diverse fields and/or between researchers and community partners. For the purposes of this funding opportunity, ‘Team Science’ is broadly defined, including multiple scientific disciplines, and encouraging but not requiring non-traditional investigators from community-based settings as co-investigators. Non-traditional co-I’s may include stakeholders who are expected in the longer term to benefit from research outcomes, such as representatives of patient and community groups, healthcare organizations, or policy makers. This award will provide funding to facilitate cross-disciplinary research projects concerning any subject area in biomedical, population health, and health services research.

University of Michigan – Michigan Institute for Clinical and Health Research (MICHR) Funding

  • MICHR Clinical and Translational Science Pilot Award
    • The MICHR Clinical and Translational Science Pilot Award aims to support new and innovative research projects relevant to clinical & translational science (CTS). CTS is a field of investigation focused on understanding a scientific or operational principle that underlies a step of the translational process, with the goal of developing generalizable principles to accelerate translational research. We encourage applications that propose addressing a common cause of inefficiency or failure in research projects at any stage of translation, with the goal of producing foundational knowledge that will ultimately improve health.

University of Pennsylvania – Institute for Translational Medicine and Therapeutics (ITMAT) Funding

  • CEAR CTSA Pilot Grant Program
    • The Community Engagement and Research (CEAR) core of the Institute for Translational Medicine and Therapeutics at the University of Pennsylvania is sponsoring a pilot grant program to fund research with public and community health relevance. The CEAR Core is seeking proposals that foster community-based research, especially studies that use a participatory framework. This includes research conducted in community settings or using a participatory research framework that actively involves community stakeholders in the conceptualization, design, implementation, and/or evaluation. “Community” is defined broadly to include populations in neighborhoods and organizations, including health care settings.

University of Pittsburgh – Clinical and Translational Science Institute (CTSI) Funding

  • CRISP: CTSI’s Research Initiative for Special Populations
    • CRISP offers campus investigators up to $25,000 in funding to support research initiatives that work with groups that are frequently underrepresented in research. Applications that demonstrate a meaningful partnership with a community organization may be eligible for an additional $5,000 in bonus funding (see the bonus round section below for additional information).
  • The Pitt Innovation Challenge
    • The Pitt Innovation Challenge (PInCh®) is seeking your bold solution to a challenging health problem. We encourage proposals from any discipline and on any topic that impacts health. Ideas can span the spectrum of health and healthcare, including disease prevention, diagnostics, treatments, interventions, predictive solutions, patient care, provider and patient tools, and community programs. We encourage projects that create new connections within the academic community, and among universities and community organizations.
  • Wordout Community Research Dissemination Challenge
    • The Community PARTners Core at the Clinical and Translational Science Institute (CTSI) is now accepting applications for the WORDOUT Community Research Dissemination Challenge. WORDOUT is an exciting program that matches researchers from the University of Pittsburgh with local community organizations to help get the “word out” about the latest in research dissemination. We are once again matching community organizations with researchers to work together to both share lived experiences of folks in the community, and think about creative ways to disseminate research.

University of Wisconsin-Madison – Institute for Clinical & Translational Research (ICTR) Funding

  • Stakeholder & Patient Engaged Research (SPER) Pilot Award
    • The goal of this Stakeholder and Patient Engaged Research (SPER) RFA is to provide support for activities that will strengthen a competitive application for external funding for research requiring strong stakeholder engagement as a foundation for a successful application. This includes but is not limited to PCOR. New or previously unsuccessful applicants to PCOR funders are encouraged to apply. (Deadline passed)
  • Clinical & Community Outcomes Research (CCOR) Pilot Award
    • The goal of the Clinical & Community Outcomes Research (CCOR) Pilot Award is to support excellent, community-partnered health research that solves problems translating knowledge into improvements in clinical practice, community programs and health policy. This pilot award may also support the development of interventions that require individual, organizational, or system behavior change. (Deadline passed)
  • Collaborative Health Equity Research (CHER) Pilot Award
    • To support new community-engaged research projects focused on health disparities/inequities wherein the PI is an early stage investigator, e.g., assistant professor, and a senior co-investigator is engaged to ensure a mentored experience and to connect the research team with relevant stakeholders. (Deadline passed)
  • Dissemination & Implementation Research (D&I) Pilot Award
    • To support research that addresses how to best ensure that evidence-based strategies/interventions/programs are effectively delivered in clinical and community health practice settings and impact policy. The successful grantee will use the results of this award to seek further extramural peer reviewed funding for the research. (Deadline passed)

Washington University in St. Louis – Institute of Clinical & Translational Sciences (ICTS) Funding

  • Clinical and Translational Research Funding Program (CTRFP)
    • As an internal grant funding program of the ICTS, the Clinical and Translational Research Funding Program (CTRFP) awards projects that promote the translation of scientific discoveries into improvement in human health. Awards will be considered for Community-Engaged Research Projects that involve established partnerships with communities and/or stakeholders whose health and well-being and/or service provision could be most impacted by the research.
  • Partnership Development & Sustainability Support (PDSS)
    • Through our Center for Community Health Partnership & Research, the ICTS launched the PDSS to provide ICTS investigators and their community partner(s) with up to $10,000 over a 9-month period to develop the trust, infrastructure, capacity, and skills needed to support future collaborative grant opportunities. The PDSS is open to new partnerships in development, as well as existing partnerships.

OTHER FUNDING OPPORTUNITIES

Other Funding Announcements

The Rising Stars In Urology Research Award: This program provides up to five years of supplemental salary support to urologists who have successfully competed for career development awards from the National Institutes of Health (NIH) or other major funding organizations. These awards ensure that the salary compensation for those committed to careers in urologic research remain competitive with that of their clinical urology peers. The program encourages recipients to contribute to urology as both surgical specialists and scientists investigating causes, prevention, treatment, and cures that will improve patients’ lives. The deadline for Letters of Intent was Tuesday, July 2, 2024. Final proposals are due on Tuesday, July 30, 2024. Please contact the Office of Research, research@auanet.org, with any questions.

The Human Tissues and Organs for Research Resource Pilot Award Program This award will cover all costs associated with obtaining up to ~10 human biospecimens to be used in a pilot study, including tissue preservation reagents and shipping costs, for an award period of up to 24 months. HTORR provides prospective procurement of human tissue samples, such that the tissue type as well as the preservation method are dictated by the researcher to best suit their projects. Essentially, researchers who are interested in acquiring human tissue samples through the group will fill out documents that detail their required tissue type, disease state (or normal state), donor medical history requirements, and any other exclusionary criteria. HTORR will then build custom protocols for the prospective collection of these tissues, and when a donor offer comes in that matches the requirements, we will provide the site with the customized collection protocol for procurement of the sample. Some examples of tissues we often procure for NIDDK researchers are: Whole kidney, Renal cortex, Renal medulla, Bladder, Ureter, Renal blood vessels, Pancreas, Stomach, Small intestine, Large intestine, Pancreatic islets.  The preliminary data generated through the completed Pilot Award study is expected to be used in at least one subsequent grant application by the end of the 2-year project period to at least one of the following NIH Institutes: National Institute of Allergy and Infectious Diseases (NIAID), the National Heart, Lung, and Blood Institute (NHLBI), the National Eye Institute (NEI), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), or the Office of Research Infrastructure Programs (ORIP). Key dates: Request for Applications Open: June 1, 2024; Application Deadline: October 1, 2024, 5 p.m. US EST; Anticipated Award Decision: December 2024; Anticipated Earliest Start Date: January 2025.

Innovative Science Accelerator Program (ISAC) The ISAC Award provides seed funding for exceptionally innovative, disruptive (high-risk/high-reward) research relevant to Kidney-Urologic-Hematologic communities that has the potential to lead to groundbreaking or paradigm-shifting results that will change the field. ISAC awards are NOT Pilot & Feasibility projects for the generation of more preliminary data for traditional NIH applications (e.g., R01). Three-page applications are accepted on a rolling basis and reviewed three times a year. Investigators may request up to $100,000 (direct + indirect costs) total costs for one year. Standard application due dates: April 15, Aug 15, Dec 15.

Ruth L. Kirschstein National Research Service Award Institutional Research Training Awards NRSA awards support the training of biomedical, behavioral, and clinical researchers through individual pre- and postdoctoral fellowships, and institutional research training grants. Search for funding opportunities by career stage HERE. NIH now provides childcare cost support to full-time predoctoral and postdoctoral trainees appointed on NRSA institutional research training awards. The NRSA childcare costs apply to each full-time predoctoral or postdoctoral NIH-NRSA-supported institutional research training award appointment. Each trainee is eligible to receive $2,500 per budget period for childcare costs provided by a licensed childcare provider.

NIH Data Book – The NIH Data Book (NDB) provides basic summary statistics on extramural grants and contract awards, grant applications, the organizations that NIH supports, the trainees and fellows supported through NIH programs, and the national biomedical workforce.